Pharma Industry Can Expect More Scrutiny From State AGs

By Gary Giampetruzzi, Anthony Jannotta and Nicole Lueddeke (March 24, 2021, 5:58 PM EDT) -- As the books have closed on a 2020 we'd all like to forget, replete with challenges associated with an unprecedented global pandemic, the legal landscape is changing, with heightened investigation and enforcement activity by state attorneys general in the pharmaceutical world....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!